In papillary thyroid carcinoma BRAFV600Eis associated with increased expression of the urokinase plasminogen activator 
and its cognate receptor, but not with disease-free interval

• Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti, Susi Barollo, Natalie Prinzi, Antonio Catania, Angela Nesca, Lucio Gnessi, Maria R. Pelizzo, Caterina Mian, Corrado De Vito, Anna Calvanese, Silvio Palermo, Severino Persechino, Enrico De Antoni, Massimino D'Armiento

• Clinical Endocrinology, October 2012, Wiley
• DOI: 10.1111/j.1365-2265.2012.04465.x